Nurse Anesthetist - CR in Huntersville, NC Accepting Medicare
5 Nurse Anesthetist - CR nurses found. Showing 1 - 5
 Dr. Sylwia Rathbun, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 10030 Gilead Rd, Huntersville, NC 28078 Phone: 704-316-4000 |
 Dustin Scott Carpenter, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 10030 Gilead Rd, Huntersville, NC 28078 Phone: 704-316-4000 |
Debra A Johnson, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 10030 Gilead Rd, Huntersville, NC 28078 Phone: 704-384-4274 Fax: 704-384-5636 |
Shirley D Davis, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 10030 Gilead Rd, Huntersville, NC 28078 Phone: 704-316-4875 |
Christine Louise Deatley, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 10030 Gilead Rd, Huntersville, NC 28078 Phone: 704-316-4875 |
News Archive
UCP2 uncoupling protein occurs mainly in cells of the immune system
When uncoupling proteins are active, mitochondria produce heat instead of ATP. This may be useful under certain circumstances, such as when an animal is hibernating. But non-hibernating animals also have them. Particularly poorly understood is the uncoupling protein UCP2. Elena Pohl and colleagues at the University of Veterinary Medicine, Vienna, show that the protein occurs mainly in cells of the immune system.
Nursing home residence may allow for 'on-admission' prediction model of C. difficile infection severity
Antibiotics may not be the only risk factor associated with community-acquired Clostridium difficile infection, indicating that other undefined causes of the potentially life-threatening infection may exist and could also predict whether or not a patient will require hospitalization, according to the results of the study, "Predictors of Hospitalization in Community-Acquired Clostridium difficile Infection."
Torax Medical's LINX Anti-Reflux treatment receives CE Mark approval
Torax Medical Inc., a medical device company focused on the minimally invasive treatment of gastro-esophageal reflux disease (GERD), has received CE Mark for its LINX® Anti-Reflux treatment. The company has started commercial launch of the LINX device at select centers in Europe.
Study shows antibody titers after natural SARS-CoV-2 infection last longer than previously thought
A recent study by researchers from the United Kingdom (UK) revealed that antibody levels associated with protection against reinfection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are likely to last from 1.5 to 2 years on average and that the protection from severe infection may be present for several years.
Everyone carries at least 1 type of pesticide
A study carried out by researchers from the Department of Radiology and Physical Medicine of the University of Granada, in collaboration with the Andalusian School of Public Health (Escuela Andaluza de Salud Publica), found that 100% of Spaniards analyzed had at least one kind of persistent organic compound (POC's), substances internationally classified as potentially harmful to one's health, in their bodies.
› Verified 8 days ago
Nurse Practitioner
Physician Assistant
Registered Nurse
Nurse Anesthetist - CR